EUVIMEDEUVIMED entdecken
Crossref

Progression of the Residual Lesion in Cavernous Sinus Extra-Axial Cavernous Hemangioma After Surgery

Ran Huo, Qifeng Yu, Hongyuan Xu, Jie Wang, Shaozhi Zhao, Jiancong Weng, Xiudan Bai, Yuming Jiao, Wenqian Zhang, Qiheng He, Zhiyou Wu, Shaowen Liu und 5 weitere

Translational Stroke Research · 2025

DOI: 10.1007/s12975-025-01333-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, 2025. Verfasst von Ran Huo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South Fourth Ring Road West, Beijing, 100070, Fengtai Distr…. Hauptthemen laut MEDLINE: Cavernous Sinus, Hemangioma, Cavernous, Hemangioma, Cavernous, Central Nervous System, Neoplasm, Residual. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Genomics Platform Construction for Chinese Major Brain Disease-AVM, Beijing Advanced Innovation Center for Big Data-based Precision Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our study aimed to investigate the factors associated with residual cavernous sinus extra-axial cavernous hemangiomas (ECHs) progression after surgery. This retrospective study consecutively included patients of cavernous sinus ECHs with incomplete lesion resection from February 2012 to January 2024. The progression of the lesions was defined as new lesions or a growth of residual lesion (≥ 10% increase in volume). Cox regression analysis was used to determine factors associated with residual lesion progression. Kaplan-Meier analysis was conducted to estimate the cumulative incidence of residual lesion progression. Sixty patients were included in this study. During the follow-up, there were 31 (51.7%) residual lesions underwent progression, whereas 29 (48.3%) patients were nonprogressive. Multivariate Cox analysis showed that the homogeneous enhancement lesion was correlated with the residual lesion progression (HR, 8.17 [95% CI, 1.03-64.58]; p = 0.046). Kaplan-Meier survival analysis indicated that the rate of homogeneous enhancement lesion progression (3.7 per 10 person-years) was significantly higher than that of the heterogeneous enhancement group (0.5 per 10 person-years; p = 0.019). Fourteen of the 31 patients with lesion progression underwent radiotherapy, and all of them experienced control over the progression of their lesions. This study found that end-of-treatment residual lesions are not rare in patients with cavernous sinus ECHs and the MRI feature is helpful to predict the progression of residual lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cavernous SinusHemangioma, CavernousHemangioma, Cavernous, Central Nervous SystemNeoplasm, ResidualHumansMaleFemaleMiddle AgedRetrospective StudiesDisease ProgressionAdultAgedMagnetic Resonance ImagingYoung AdultAdolescent

Stichwörter der Autor:innen

Extra-cavernous hemangiomasMagnetic resonance imagingResidual lesion progressionSurgical treatment

Autor:innen und Institutionen

  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South Fourth Ring Road West, Beijing, 100070, Fengtai District, China.
  • China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Department of Neurosurgery, China-Japan Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 South Fourth Ring Road West, Beijing, 100070, Fengtai District, China. caoyong@bjtth.org.
  • China National Clinical Research Center for Neurological Diseases, Beijing, China. caoyong@bjtth.org.
  • Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. caoyong@bjtth.org.

Förderung

  • National Natural Science Foundation of China
  • Genomics Platform Construction for Chinese Major Brain Disease-AVM
  • Beijing Advanced Innovation Center for Big Data-based Precision Medicine

Zitieren

APA

Huo, R., Yu, Q., Xu, H., Wang, J., Zhao, S., Weng, J., Bai, X., Jiao, Y., Zhang, W., He, Q., Wu, Z., Liu, S., Sun, Y., Ni, Y., Tang, J., Wang, S., & Cao, Y. (2025). Progression of the Residual Lesion in Cavernous Sinus Extra-Axial Cavernous Hemangioma After Surgery. Translational Stroke Research. https://doi.org/10.1007/s12975-025-01333-5

Vancouver

Huo R, Yu Q, Xu H, Wang J, Zhao S, Weng J, et al. Progression of the Residual Lesion in Cavernous Sinus Extra-Axial Cavernous Hemangioma After Surgery. Translational Stroke Research. 2025. doi:10.1007/s12975-025-01333-5

BibTeX
@article{Huo2025,
  author = {Huo, Ran and Yu, Qifeng and Xu, Hongyuan and Wang, Jie and Zhao, Shaozhi and Weng, Jiancong and Bai, Xiudan and Jiao, Yuming and Zhang, Wenqian and He, Qiheng and Wu, Zhiyou and Liu, Shaowen and Sun, Yingfan and Ni, Yang and Tang, Jinyi and Wang, Shuo and Cao, Yong},
  title = {Progression of the Residual Lesion in Cavernous Sinus Extra-Axial Cavernous Hemangioma After Surgery},
  journal = {Translational Stroke Research},
  year = {2025},
  doi = {10.1007/s12975-025-01333-5}
}
Kostenlos starten →